Sara E. Cosgrove

2001–2025 年に発表

別表記
Sara E Cosgrove
132
論文数
36,839
被引用数
79
h 指数
126
i10 指数

被引用数

Sara E. Cosgrove の年別被引用数1964 年: 被引用 1 件1976 年: 被引用 1 件1984 年: 被引用 1 件1989 年: 被引用 1 件1991 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 4 件2002 年: 被引用 6 件2003 年: 被引用 28 件2004 年: 被引用 61 件2005 年: 被引用 105 件2006 年: 被引用 124 件2007 年: 被引用 165 件2008 年: 被引用 204 件2009 年: 被引用 225 件2010 年: 被引用 242 件2011 年: 被引用 256 件2012 年: 被引用 266 件2013 年: 被引用 314 件2014 年: 被引用 281 件2015 年: 被引用 281 件2016 年: 被引用 242 件2017 年: 被引用 287 件2018 年: 被引用 319 件2019 年: 被引用 1,241 件2020 年: 被引用 1,080 件2021 年: 被引用 921 件2022 年: 被引用 738 件2023 年: 被引用 627 件2024 年: 被引用 971 件2025 年: 被引用 483 件2026 年: 被引用 29 件1965〜1975 年は被引用が無いため表示していません1977〜1983 年は被引用が無いため表示していません1985〜1988 年は被引用が無いため表示していません1990 年は被引用が無いため表示していません1992〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,653 件、この内訳の 29.7%イギリス: 引用元論文 793 件、この内訳の 6.5%中国: 引用元論文 644 件、この内訳の 5.3%イタリア: 引用元論文 463 件、この内訳の 3.8%オーストラリア: 引用元論文 458 件、この内訳の 3.7%カナダ: 引用元論文 444 件、この内訳の 3.6%ドイツ: 引用元論文 414 件、この内訳の 3.4%フランス: 引用元論文 385 件、この内訳の 3.1%スペイン: 引用元論文 369 件、この内訳の 3%オランダ: 引用元論文 323 件、この内訳の 2.6%スイス: 引用元論文 286 件、この内訳の 2.3%日本: 引用元論文 235 件、この内訳の 1.9%
0%29.7%その他 31.1%

分野

  • Medicine50.1%
  • Biochemistry, Genetics and Molecular Biology19.7%
  • Immunology and Microbiology16%
  • Health Professions7%
  • Environmental Science1.6%
  • Agricultural and Biological Sciences0.9%
  • その他4.7%

トピック

  • Antibiotic Use and Resistance7.9%
  • Antimicrobial Resistance in Staphylococcus7%
  • Antibiotic Resistance in Bacteria6.7%
  • Bacterial Identification and Susceptibility Testing5.5%
  • Antibiotics Pharmacokinetics and Efficacy4.3%
  • Nosocomial Infections in ICU3.6%
  • その他65%

共著者

全論文

検索で開く
  1. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, John J.P. Kastelein, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Brendan Everett, Les B. Forgosh, Robert J. Glynn, Barry Harris, Peter Libby, M Ligueros, Tom Thurén, Erin A. Bohula, Bindu Charmarthi, Susan Cheng, Sherry Chou, Jacqueline Suk Danik, Graham T. McMahon, Bradley A. Maron, MingMing Ning, Benjamin A. Olenchock, Reena L. Pande, Todd S. Perlstein, Aruna D. Pradhan, Natalia S. Rost, Aneesh B. Singhal, Viviany R. Taqueti, Nancy Wei, Howard A. Burris, Angela Cioffi, Anne Marie Dalseg, Nilanjan Ghosh, Julie R. Gralow, Tina Mayer, Hope S. Rugo, Vance G. Fowler, Ajit P. Limaye, Sara E. Cosgrove, Donald P. Levine, Renato D. Lópes, John Scott, Tom Thurén, M Ligueros, Robert Hilkert, Georgia Tamesby, Carolyn Mickel, Brian Manning, Julian Woelcke, Monique Tan, S Manfreda ほか 19 名 - The Lancet 2017 被引用: 1,308

  2. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

    著者: , , , , , , , , , , , , - Clinical Infectious Diseases 2011 被引用: 4,179

  3. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2016 被引用: 2,983

  4. Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis

    著者: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 311

  5. Association of Adverse Events With Antibiotic Use in Hospitalized Patients

    著者: , , , , - JAMA Internal Medicine 2017 被引用: 778

  6. Combination Therapy for Treatment of Infections with Gram-Negative Bacteria

    著者: , , - Clinical Microbiology Reviews 2012 被引用: 829

  7. The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs

    著者: - Clinical Infectious Diseases 2005 被引用: 1,287

  8. Factors driving provider adoption of the TREWS machine learning-based early warning system and its effects on sepsis treatment timing

    著者: , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 112

  9. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

    著者: , , , , , , , , , , , , - Clinical Infectious Diseases 2011 被引用: 1,599

  10. Global incidence in hospital-associated infections resistant to antibiotics: An analysis of point prevalence surveys from 99 countries

    著者: , , , , - PLoS Medicine 2023 被引用: 126

  11. An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2006 被引用: 4,380

  12. Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)

    著者: , , , , , , , , , , , - Clinical Infectious Diseases 2015 被引用: 343

  13. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2006 被引用: 1,463

  14. WHO global research priorities for antimicrobial resistance in human health

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George F Araj, Marlen Arce Villalobos, Christine Årdal, Diane Ashiru-Oredope, Elizabeth A Ashley, François-Xavier Babin, Laura H Bachmann, Till Bachmann, Kate Susan Baker, Manica Balasegaram, Colleen Bamford, Fernando Baquero, Laura Isabel Barcelona, Quique Bassat, Matteo Bassetti, Sulagna Basu, Justin Beardsley, Grey Benoit Vásquez, James A Berkley, Anuj K Bhatnagar, Julia Bielicki, Julie Bines, Felix Bongomin, Robert A Bonomo, John S Bradley, Catriona Bradshaw, Ana Brett, Adrian Brink, Colin Brown, Jeremy Brown, Kirsty Buising, Carolee Carson, Anna Cristina Carvalho, Elio Castagnola, Marco Cavaleri, Michele Cecchini, Chishala Chabala, Richard E Chaisson, Arunaloke Chakrabarti, Clare Chandler, Sujith John Chandy, Esmita Charani, Lisa Chen, Francesca Chiara, Anuradha Chowdhary, Arlene Chua, Pem Chuki, Doo Ryeon Chun, Gavin Churchyard, Daniela Cirillo, Lauren Clack, Susan E Coffin, Jennifer Cohn, Michelle Cole, John Conly, Ben Cooper, Alejandra Corso, Sara E Cosgrove, Helen Cox, Charles L Daley, Saffiatou Darboe, Tom Darton, Gerry Davies, Viviana de Egea, Amela Dedeić-Ljubović, Miranda Deeves, Claudia Denkinger, Jo-Anne R Dillon, Angela Dramowski, Brian Eley ほか 184 名 - The Lancet Microbe 2024 被引用: 187

  15. Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 102

  16. Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysis

    著者: , , , , , - Clinical Infectious Diseases 2003 被引用: 1,960

  17. Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure

    著者: , , , , , , , , , , , , - Clinical Infectious Diseases 2020 被引用: 203

  18. Cefiderocol Activity Against ClinicalPseudomonas aeruginosaIsolates Exhibiting Ceftolozane-Tazobactam Resistance

    著者: , , , , , - Open Forum Infectious Diseases 2021 被引用: 79

  19. Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia

    著者: , , , , , , , , , , , - JAMA Internal Medicine 2019 被引用: 153

  20. Does This Patient Need Blood Cultures? A Scoping Review of Indications for Blood Cultures in Adult Nonneutropenic Inpatients

    著者: , , , , , - Clinical Infectious Diseases 2020 被引用: 151

  21. Comparing Propensity Score Methods Versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections

    著者: , , , , , , - Clinical Infectious Diseases 2020 被引用: 92

  22. A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase–Producing Organism

    著者: , , , , , , , , - Clinical Infectious Diseases 2016 被引用: 174

  23. Blood Culture Utilization in the Hospital Setting: a Call for Diagnostic Stewardship

    著者: , , - Journal of Clinical Microbiology 2021 被引用: 118

  24. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum

    著者: , , , , , , , , , - Antimicrobial Resistance and Infection Control 2013 被引用: 451